Categories: Health

RAMSAY SANTE : closing repricing 250217

PRESS RELEASE

Paris, 17 February 2025

Ramsay Santé has successfully repriced its €1,025m TLB4 and extended for 2 years its €425m TLB3, both merged in a new single Term Loan B5

  • Ramsay Santé today announced that it has repriced its €1,025m TLB4 from E+4.00% to E+3.25%                    / 100 OID (same maturity, i.e. August 2031).
  • Simultaneously, the group has extended for 2 years the maturity of its former €425m TLB3 from August 2029 to August 2031 (same margin, i.e. E+3.25%).
  • Consequently, TLB3 and TLB4 have been merged into a new single Term Loan B5 of €1,450m maturing August 2031, priced at E+3.25%.
  • Through this transaction, Ramsay Santé has managed to optimize its cost of debt and further extend its debt maturities.
  • This transaction was arranged by BNP Paribas and Crédit Agricole CIB as Physical Bookrunners.

About Ramsay Santé 
Ramsay Santé is the leader in private hospitalisation and primary care in Europe. The Group has 38,000 employees and works with nearly 9,300 practitioners to treat more than 12 million patients per year in its 465 facilities and 5 countries: France, Sweden, Norway, Denmark and Italy. Ramsay Santé offers almost all medical and surgical specialities in three domains: Medicine, Surgery, Obstetrics (MSO), Follow-up Care and Rehabilitation (FCR) and Mental Health. 
Legally, Ramsay Santé is a mission-driven company committed to constantly improving the health of all patients through innovation. Wherever it operates, the Group contributes to public health service missions and the healthcare network. Through its actions and the constant dedication of its teams, Ramsay Santé is committed to ensuring the entire patient care journey, from prevention to follow-up care. 
Every year, the group invests over 200 million euros to support the evolution and diversity of care pathways, in medical, hospital, digital, and administrative aspects. Through this commitment, our Group enhances access to care for all, commits to provides best-in-class healthcare, systematically engages in dialogue with stakeholders and strives to protect the planet to improve health. 

Facebook: https://www.facebook.com/RamsaySante 
Instagram: https://www.instagram.com/ramsaysante 
Twitter: https://twitter.com/RamsaySante 
LinkedIn: https://www.linkedin.com/company/ramsaysante 
YouTube: https://www.youtube.com/c/RamsaySante 

Code ISIN and Euronext Paris: FR0000044471 
Website:  www.ramsaysante.fr 

                               Investor / Analyst Relations                                                      Press Relations

Clément Lafaix                                                        Brigitte Cachon
Tel. +33 1 87 86 21 52                                                Tel. +33 1 87 86 22 11
clement.lafaix@ramsaysante.fr                                        brigitte.cachon@ramsaysante.fr 

GlobeNews Wire

Recent Posts

Scenic Biotech Announces Nature Publication on the Discovery of Drug Target PLA2G15, a Modifier in Lysosomal Disease

In collaboration with a Stanford University research team, Scenic Biotech identified and characterized PLA2G15 as…

1 hour ago

Virbac : Declaration of the number of shares and voting rights 04/2025

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of…

1 hour ago

Updated full-year outlook for 2025 as a result of DTK closing, market conditions and M&A integration projects

Company announcement no. 07 – 25 7 May 2025 Updated full-year outlook for 2025 as…

1 hour ago

TerrAscend Closes on Ohio Dispensary Acquisition

May 07, 2025 10:00 ET  | Source: TerrAscend Transaction marks the Company’s entry into its…

1 hour ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 07, 2025 10:00 ET  | Source: SeaStar Medical DENVER, May 07, 2025 (GLOBE NEWSWIRE)…

1 hour ago

Kia America Announces 2026 Sportage Pricing

Sportage has starting MSRP1 of $28,690Dynamic facelifted exterior design features broad, upright grille that conveys…

1 hour ago